Centre Hospitalier Universitaire Vaudois
Clinical trials sponsored by Centre Hospitalier Universitaire Vaudois, explained in plain language.
-
Stroke patients try intensive Tech-Powered rehab in swiss study
Disease control Recruiting nowThis study tests whether a high-dose, high-intensity neurorehabilitation program using digital devices (MindMotion GO, Izar) is feasible for stroke patients. 120 adults with stroke will train about one hour per day, five days a week, across inpatient and home settings. The goal i…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated Jun 23, 2026 16:31 UTC
-
Bladder surgery patients may benefit from Pre-Op nutrition drink
Disease control Recruiting nowThis study tests whether giving patients a special nutritional drink (immunonutrition) before bladder removal surgery can reduce complications like infections. About 232 adults having open cystectomy for various bladder conditions will be randomly assigned to receive the drink or…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated Jun 22, 2026 12:08 UTC
-
Knee cartilage repair: your own cells could be the key
Disease control Recruiting nowThis study is testing a procedure called autologous chondrocyte implantation (ACI) for people with knee cartilage defects. Doctors take a sample of the patient's own cartilage cells, grow them in a lab, and then implant them into the damaged area. The goal is to see if this appro…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated Jun 22, 2026 11:57 UTC
-
New triple therapy hopes to stall aggressive brain tumors
Disease control Recruiting nowThis study tests whether combining three drugs (trimipramine, atezolizumab, and bevacizumab) can help control recurrent glioblastoma, an aggressive brain cancer. About 59 participants will receive the treatment for up to 2 years, with some undergoing surgery to measure drug level…
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated Jun 17, 2026 12:08 UTC
-
Personalized cell therapy LauT-1 enters early human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new treatment called LauT-1 for people with advanced melanoma or sarcoma that has not responded to standard therapies. LauT-1 uses a patient's own immune cells, which are modified in a lab to better recognize and attack cancer cells. The main goals …
Phase: PHASE1 • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
Your phone may soon check your blood pressure – no cuff needed!
Diagnosis Recruiting nowThis study explores whether a smartphone can reliably screen for high blood pressure by analyzing video recorded at your fingertip. About 100 adults will record their blood pressure using both a smartphone and a standard arm cuff, three times each morning and evening for a week. …
Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Diagnosis
Last updated Jun 17, 2026 12:03 UTC
-
Ultrasound-Guided numbing may reduce pain and opioid use in child circumcisions
Symptom relief Recruiting nowThis study tests whether using ultrasound to guide a numbing injection for circumcision works better than the standard method based on feel. About 216 boys under 18 will be randomly assigned to one of two groups. The goal is to see if ultrasound reduces the need for strong painki…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Symptom relief
Last updated Jun 12, 2026 12:08 UTC
-
AI predicts tough intubations: could save lives in surgery
Knowledge-focused Recruiting nowThis study aims to create a portable, radiation-free software that uses facial recognition and neck movement analysis to predict how difficult it will be to place a breathing tube during anesthesia. Researchers will enroll 1800 adults undergoing planned surgery to test the softwa…
Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:10 UTC